中文版 | English

在结果中检索

CCPortal

浏览/检索结果: 共5条，第1-5条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Analysis and practice for observing artificially triggered lightning with a ground-based microwave radiometer 期刊论文
Atmospheric Research, 2021, 卷号: 264
作者:  Jiang S.;  Wang Z.;  Liu C.;  Lu J.;  Lei L.;  Pan Y.;  Li Q.;  Lyu W.;  Zhang Y.
收藏  |  浏览/下载：124/0  |  提交时间：2021/11/15
Bypassing the NOx titration trap in ozone pollution control in Beijing 期刊论文
Atmospheric Research, 2021, 卷号: 249
作者:  Tang G.;  Liu Y.;  Zhang J.;  Liu B.;  Li Q.;  Sun J.;  Wang Y.;  Xuan Y.;  Li Y.;  Pan J.;  Li X.;  Wang Y.
收藏  |  浏览/下载：28/0  |  提交时间：2020/11/23
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
收藏  |  浏览/下载：39/0  |  提交时间：2021/09/01
Carfloglitazar  Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes  
Spatially explicit analysis identifies significant potential for bioenergy with carbon capture and storage in China 期刊论文
Nature Communications, 2021, 卷号: 12, 期号: 1
作者:  Xing X.;  Wang R.;  Bauer N.;  Ciais P.;  Cao J.;  Chen J.;  Tang X.;  Wang L.;  Yang X.;  Boucher O.;  Goll D.;  Peñuelas J.;  Janssens I.A.;  Balkanski Y.;  Clark J.;  Ma J.;  Pan B.;  Zhang S.;  Ye X.;  Wang Y.;  Li Q.;  Luo G.;  Shen G.;  Li W.;  Yang Y.;  Xu S.
收藏  |  浏览/下载：29/0  |  提交时间：2022/02/22
Chiglitazar monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomized, double-blind, phase 3 trial (CMAS) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Jia W.;  Ma J.;  Miao H.;  Wang C.;  Wang X.;  Li Q.;  Lu W.;  Yang J.;  Zhang L.;  Yang J.;  Wang G.;  Zhang X.;  Zhang M.;  Sun L.;  Yu X.;  Du J.;  Shi B.;  Xiao C.;  Zhu D.;  Liu H.;  Zhong L.;  Xu C.;  Xu Q.;  Liang G.;  Zhang Y.;  Li G.;  Gu M.;  Liu J.;  Yuan G.;  Yan Z.;  Yan D.;  Ye S.;  Zhang F.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Ji L.
收藏  |  浏览/下载：39/0  |  提交时间：2021/09/01
Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes